Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

PTLA

Portola Pharmaceuticals (PTLA)

Portola Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTLA
DateHeureSourceTitreSymboleSociété
23/12/201620h12GlobeNewswire Inc.Portola Pharmaceuticals Announces FDA Accepts New Drug Application for Priority Review and EMA Validates Marketing Authorizat...NASDAQ:PTLAPortola Pharmaceuticals Inc
22/12/201622h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
19/12/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Enters into $50 Million Loan Agreement with Bristol-Myers Squibb and Pfizer for Continued Development...NASDAQ:PTLAPortola Pharmaceuticals Inc
28/11/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces AndexXa™ (andexanet alfa), Betrixaban and Cerdulatinib Data to be Presented at 2016 Ameri...NASDAQ:PTLAPortola Pharmaceuticals Inc
14/11/201622h15GlobeNewswire Inc.Portola Pharmaceuticals Announces Three Phase 3 APEX Substudy Results Showing Further Benefits of Treating Acute Medically Il...NASDAQ:PTLAPortola Pharmaceuticals Inc
07/11/201623h42Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTLAPortola Pharmaceuticals Inc
07/11/201622h05GlobeNewswire Inc.Portola Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
07/11/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces New APEX Study Sub-Analyses Data to be Presented at American Heart Association Scientific S...NASDAQ:PTLAPortola Pharmaceuticals Inc
02/11/201613h00GlobeNewswire Inc.Portola Pharmaceuticals to Present at the Credit Suisse 25th Annual Healthcare ConferenceNASDAQ:PTLAPortola Pharmaceuticals Inc
01/11/201613h00GlobeNewswire Inc.Portola Pharmaceuticals Expands Clinical Collaboration Agreement with Daiichi Sankyo Worth Up to $25 Million to Develop Andex...NASDAQ:PTLAPortola Pharmaceuticals Inc
31/10/201613h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce Third Quarter 2016 Financial Results and Host Conference Call on Monday, November 7NASDAQ:PTLAPortola Pharmaceuticals Inc
25/10/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Submits New Drug Application to U.S. FDA for Betrixaban for Extended Duration Prophylaxis of Venous T...NASDAQ:PTLAPortola Pharmaceuticals Inc
14/10/201600h07GlobeNewswire Inc.Portola Pharmaceuticals Supports “World Thrombosis Day” Campaign to Increase Awareness of Risks of Blood ClotsNASDAQ:PTLAPortola Pharmaceuticals Inc
13/09/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Upcoming Data Presentations on AndexXa™ (andexanet alfa) at Neurocritical Care Society 2...NASDAQ:PTLAPortola Pharmaceuticals Inc
12/09/201617h02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTLAPortola Pharmaceuticals Inc
30/08/201610h01GlobeNewswire Inc.Portola Pharmaceuticals Announces Interim Results from Ongoing Phase 3b/4 ANNEXXA-4™ Study of Factor Xa Inhibitor Antidote ...NASDAQ:PTLAPortola Pharmaceuticals Inc
26/08/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Presentation of Interim Results from Phase 3b/4 ANNEXA™-4 Study of AndexXa™ (andexanet ...NASDAQ:PTLAPortola Pharmaceuticals Inc
19/08/201614h30GlobeNewswire Inc.Portola Pharmaceuticals Announces Validation of Marketing Authorization Application (MAA) by European Medicines Agency (EMA) ...NASDAQ:PTLAPortola Pharmaceuticals Inc
18/08/201604h57GlobeNewswire Inc.Portola Pharmaceuticals Receives Complete Response Letter from FDA for Biologics License Application for AndexXa™ (andexane...NASDAQ:PTLAPortola Pharmaceuticals Inc
09/08/201622h05GlobeNewswire Inc.Portola Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
02/08/201622h05GlobeNewswire Inc.Portola Pharmaceuticals to Announce Second Quarter 2016 Financial Results and Host Conference Call on Tuesday, August 9NASDAQ:PTLAPortola Pharmaceuticals Inc
22/06/201614h20PR Newswire (US)Biotechnology Stocks in Motion -- Minerva Neurosciences, Portola Pharma, Trevena, and Anthera PharmaNASDAQ:PTLAPortola Pharmaceuticals Inc
21/06/201623h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTLAPortola Pharmaceuticals Inc
14/06/201612h05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
01/06/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Dosing of First Patient in Phase 2a Study of Cerdulatinib for Treatment of Hematologic Canc...NASDAQ:PTLAPortola Pharmaceuticals Inc
31/05/201622h05GlobeNewswire Inc.Portola Pharmaceuticals to Present at Goldman Sachs 37th Annual Global Healthcare ConferenceNASDAQ:PTLAPortola Pharmaceuticals Inc
27/05/201614h45GlobeNewswire Inc.Portola Pharmaceuticals Announces Full Results of Phase 3 APEX Study of Betrixaban Presented at International Society on Thro...NASDAQ:PTLAPortola Pharmaceuticals Inc
24/05/201618h23Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PTLAPortola Pharmaceuticals Inc
23/05/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Upcoming Data Presentations on Betrixaban and AndexXa™ (andexanet alfa) at International ...NASDAQ:PTLAPortola Pharmaceuticals Inc
19/05/201614h35PR Newswire (US)How are Investors Treating These Biotech? - Portola Pharma, Vitae Pharma, Anthera Pharma, and Intra-Cellular TherapiesNASDAQ:PTLAPortola Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTLA